Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TDO2 Promotes the EMT of Hepatocellular Carcinoma Through Kyn-AhR Pathway
Lei Li, Tao Wang, Shanbao Li, et al.
Frontiers in Oncology (2021) Vol. 10
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Tryptophan metabolism in health and disease
Xue Chen, Ganglei Li, Qiuxian Zheng, et al.
Cell Metabolism (2023) Vol. 35, Iss. 8, pp. 1304-1326
Open Access | Times Cited: 338
Indoleamine 2,3-dioxygenase (IDO) inhibitors and cancer immunotherapy
Yu Fujiwara, Shumei Kato, Mary Nesline, et al.
Cancer Treatment Reviews (2022) Vol. 110, pp. 102461-102461
Open Access | Times Cited: 173
Modulation of T cells by tryptophan metabolites in the kynurenine pathway
Trevor W. Stone, Richard Williams
Trends in Pharmacological Sciences (2023) Vol. 44, Iss. 7, pp. 442-456
Open Access | Times Cited: 76
Tryptophan metabolism in digestive system tumors: unraveling the pathways and implications
Yu Liang, Juan Lu, Weibo Du
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 16
New insights into checkpoint inhibitor immunotherapy and its combined therapies in hepatocellular carcinoma: from mechanisms to clinical trials
Haoer Jin, Sha Qin, Jiang He, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 7, pp. 2775-2794
Open Access | Times Cited: 44
Involvement of the kynurenine pathway in breast cancer: updates on clinical research and trials
Hemaasri-Neya Girithar, Ananda Staats Pires, Seong Beom Ahn, et al.
British Journal of Cancer (2023) Vol. 129, Iss. 2, pp. 185-203
Open Access | Times Cited: 25
Recent advances in clinical trials targeting the kynurenine pathway
Ananda Staats Pires, Gayathri Sundaram, Benjamin Heng, et al.
Pharmacology & Therapeutics (2021) Vol. 236, pp. 108055-108055
Closed Access | Times Cited: 46
Macrophage metabolism, phenotype, function, and therapy in hepatocellular carcinoma (HCC)
Jingquan Huang, Qiulin Wu, David A. Geller, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 22
Effects of 3‐HAA on HCC by Regulating the Heterogeneous Macrophages—A scRNA‐Seq Analysis
Chen Xue, Xinyu Gu, Qiuxian Zheng, et al.
Advanced Science (2023) Vol. 10, Iss. 16
Open Access | Times Cited: 20
Harnessing function of EMT in hepatocellular carcinoma: From biological view to nanotechnological standpoint
Yaser E. Alqurashi, Hussein Riyadh Abdul Kareem Al‐Hetty, Pushpamala Ramaiah, et al.
Environmental Research (2023) Vol. 227, pp. 115683-115683
Closed Access | Times Cited: 18
Stemness and immune evasion conferred by the TDO2‐AHR pathway are associated with liver metastasis of colon cancer
Toshiaki Miyazaki, Suyoun Chung, Hiroaki Sakai, et al.
Cancer Science (2021) Vol. 113, Iss. 1, pp. 170-181
Open Access | Times Cited: 40
CPNE8 Promotes Gastric Cancer Metastasis by Modulating Focal Adhesion Pathway and Tumor Microenvironment
Peiling Zhang, Xiaofei Cao, Mingmei Guan, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 13, pp. 4932-4949
Open Access | Times Cited: 26
Forces at play: exploring factors affecting the cancer metastasis
Farooq Riaz, Jing Zhang, Fan Pan
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
The potential of aryl hydrocarbon receptor as receptors for metabolic changes in tumors
Zhiying Wang, Yuanqi Zhang, Zhihong Liao, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 4
The aryl hydrocarbon receptor as a tumor modulator: mechanisms to therapy
Kanita A. Chaudhry, Anna Bianchi
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 4
Tryptophan-2,3-Dioxygenase as a Therapeutic Target in Digestive System Diseases
Zhengsen Wang, Xin Xie, Yu Xue, et al.
Biology (2025) Vol. 14, Iss. 3, pp. 295-295
Open Access
Aryl hydrocarbon receptor-regulated long non-coding RNAs: implications for glycolipid metabolism and prognosis in hepatocellular carcinoma
Xiaoli Xiao, Yao Liu, Xiaoyong Qu, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Resveratrol and Its Analogs: Potent Agents to Reverse Epithelial-to-Mesenchymal Transition in Tumors
Kaibo Guo, Yuqian Feng, Xueer Zheng, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 24
The Gut Microbiota Activates AhR Through the Tryptophan Metabolite Kyn to Mediate Renal Cell Carcinoma Metastasis
Guoyu Dai, Xiang Chen, Yao He
Frontiers in Nutrition (2021) Vol. 8
Open Access | Times Cited: 21
Gastric Cancer Cell-Derived Kynurenines Hyperactive Regulatory T Cells to Promote Chemoresistance via the IL-10/STAT3/BCL2 Signaling Pathway
Dandan Wu, Zhongli Wang
DNA and Cell Biology (2022) Vol. 41, Iss. 4, pp. 447-455
Open Access | Times Cited: 16
Potential of Targeting TDO2 as the Lung Adenocarcinoma Treatment
Er Jin, Zhidong Yin, Xiuxiu Zheng, et al.
Journal of Proteome Research (2024) Vol. 23, Iss. 4, pp. 1341-1350
Closed Access | Times Cited: 2
Amino acid metabolic reprogramming in the tumor microenvironment and its implication for cancer therapy
Jiarong Zhang, Mingjian Chen, Yuxin Yang, et al.
Journal of Cellular Physiology (2024) Vol. 239, Iss. 11
Closed Access | Times Cited: 2
Involvement of Kynurenine Pathway in Hepatocellular Carcinoma
Shivani Krishnamurthy, David Gilot, Seong Beom Ahn, et al.
Cancers (2021) Vol. 13, Iss. 20, pp. 5180-5180
Open Access | Times Cited: 15
Tryptophan 2,3-dioxygenase may be a potential prognostic biomarker and immunotherapy target in cancer: A meta-analysis and bioinformatics analysis
Yanyan Hu, Zhong‐Jian Liu, Hui Tang
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 9
Research progress of targeted therapy combined with immunotherapy for hepatocellular carcinoma
Shuqi Xie, Mengchao Wang, Chuanxiu Zeng, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top